Kemp PR - Search Results

1

Transforming growth factor-beta1 gene polymorphisms and coronary artery disease.

Syrris P, Carter ND, Metcalfe JC, Kemp PR, Grainger DJ, Kaski JC, Crossman DC, Francis SE, Gunn J, Jeffery S, Heathcote K. Syrris P, et al. Among authors: kemp pr. Clin Sci (Lond). 1998 Dec;95(6):659-67. doi: 10.1042/cs0950659. Clin Sci (Lond). 1998. PMID: 9831690

2

The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis.

Grainger DJ, Kemp PR, Metcalfe JC, Liu AC, Lawn RM, Williams NR, Grace AA, Schofield PM, Chauhan A. Grainger DJ, et al. Among authors: kemp pr. Nat Med. 1995 Jan;1(1):74-9. doi: 10.1038/nm0195-74. Nat Med. 1995. PMID: 7584958

3

Genetic control of the circulating concentration of transforming growth factor type beta1.

Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD. Grainger DJ, et al. Among authors: kemp pr. Hum Mol Genet. 1999 Jan;8(1):93-7. doi: 10.1093/hmg/8.1.93. Hum Mol Genet. 1999. PMID: 9887336

4

Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice.

Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC. Grainger DJ, et al. Among authors: kemp pr. Nature. 1994 Aug 11;370(6489):460-2. doi: 10.1038/370460a0. Nature. 1994. PMID: 8047165

5

Transforming growth factor beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase.

Grainger DJ, Kemp PR, Witchell CM, Weissberg PL, Metcalfe JC. Grainger DJ, et al. Among authors: kemp pr. Biochem J. 1994 Apr 1;299 ( Pt 1)(Pt 1):227-35. doi: 10.1042/bj2990227. Biochem J. 1994. PMID: 8166645 Free PMC article.

6

Cloning and analysis of the promoter region of the rat SM22 alpha gene.

Kemp PR, Osbourn JK, Grainger DJ, Metcalfe JC. Kemp PR, et al. Biochem J. 1995 Sep 15;310 ( Pt 3)(Pt 3):1037-43. doi: 10.1042/bj3101037. Biochem J. 1995. PMID: 7575400 Free PMC article.

7

Active and acid-activatable TGF-beta in human sera, platelets and plasma.

Grainger DJ, Mosedale DE, Metcalfe JC, Weissberg PL, Kemp PR. Grainger DJ, et al. Among authors: kemp pr. Clin Chim Acta. 1995 Feb 28;235(1):11-31. doi: 10.1016/0009-8981(94)05995-4. Clin Chim Acta. 1995. PMID: 7634487

8

Expression of alternatively spliced human latent transforming growth factor beta binding protein-1.

Oklü R, Hesketh TR, Metcalfe JC, Kemp PR. Oklü R, et al. Among authors: kemp pr. FEBS Lett. 1998 Sep 18;435(2-3):143-8. doi: 10.1016/s0014-5793(98)01054-0. FEBS Lett. 1998. PMID: 9762896 Free article.

9

Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer.

Lücke CD, Philpott A, Metcalfe JC, Thompson AM, Hughes-Davies L, Kemp PR, Hesketh R. Lücke CD, et al. Among authors: kemp pr. Cancer Res. 2001 Jan 15;61(2):482-5. Cancer Res. 2001. PMID: 11212236

10

ID--a dominant negative regulator of skeletal muscle differentiation--is not involved in maturation or differentiation of vascular smooth muscle cells.

Kemp PR, Metcalfe JC, Grainger DJ. Kemp PR, et al. FEBS Lett. 1995 Jul 10;368(1):81-6. doi: 10.1016/0014-5793(95)00605-9. FEBS Lett. 1995. PMID: 7615094 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters